Calcitonin gene-related peptide receptor antagonists

Jan 07, 2019

Biohaven Announces Acceptance Of Investigational New Drug (IND) Filing For Rimegepant In China

Nov 15, 2018

Biohaven Enrolls First Patient In Phase 3 Preventive Treatment Of Migraine Trial With Its Oral CGRP Receptor Antagonist Rimegepant

Nov 14, 2018

Biohaven Pharmaceuticals Reports Third Quarter 2018 Financial And Recent Business Results